Recombitek C4 from Boehringer Ingelheim is a canine biological combining a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus with modified live adenovirus type 2, parainfluenza virus, and parvovirus. Supplied with a sterile water diluent, each dose is 1 ml and packaged in a clinic-friendly 25 x 1 ml format. This dog vaccine leverages recombinant canarypox technology alongside modified live viral fractions. Intended for dogs; use according to the manufacturer’s label directions.